Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Takeda

Showing results (31-40 of 128) with videos related to

Pageof 13
Sort By:
Frontiers in Pharmacology|September 24, 2021
Renal ROCK Activation and Its Pharmacological Inhibition in Patients With DiabetesKeiichiro Matoba, Kensuke Sekiguchi, Yosuke Nagai, et al.
International Journal of Hematology|August 11, 2012
Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapyHiroaki Tanaka, Shinichiro Hashimoto, Yasumasa Sugita, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|June 19, 2012
Hepatitis B reactivation in a multiple myeloma patient with resolved hepatitis B infection during bortezomib therapy : case reportHiroaki Tanaka, Ikuo Sakuma, Shinichiro Hashimoto, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|December 27, 2013
Secondary neurolymphomatosis detected by whole-body diffusion-weighted magnetic resonance imaging: a case reportHiroaki Tanaka, Kazuhiro Yoshino, Emiko Sakaida, et al.
Journal of Arrhythmia|October 13, 2017
Adaptive cardiac resynchronization therapy for dilated cardiomyopathy with functional mitral regurgitationYoshiki Nagata, Yoichiro Nakagawa, Yusuke Takeda, et al.
International Journal of Molecular Sciences|May 20, 2017
SGLT2 Inhibitors as a Therapeutic Option for Diabetic NephropathyDaiji Kawanami, Keiichiro Matoba, Yusuke Takeda, et al.
JMA Journal|November 5, 2020
ROCK Inhibition May Stop Diabetic Kidney DiseaseKeiichiro Matoba, Yusuke Takeda, Yosuke Nagai, et al.
Clinics and Practice|July 25, 2024
A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline TreatmentHiroshi Ureshino, Yusuke Takeda, Kazuharu Kamachi, et al.
Neuroimage|July 1, 2023
Sensor array design of optically pumped magnetometers for accurately estimating source currentsYusuke Takeda, Tomohiro Gomi, Ryu Umebayashi, et al.
International Journal of Molecular Sciences|August 19, 2017
Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic NephropathyKeiichiro Matoba, Daiji Kawanami, Yosuke Nagai, et al.
Pageof 13

Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
Frontiers in Pharmacology|September 24, 2021
Renal ROCK Activation and Its Pharmacological Inhibition in Patients With DiabetesKeiichiro Matoba, Kensuke Sekiguchi, Yosuke Nagai, et al.
International Journal of Hematology|August 11, 2012
Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapyHiroaki Tanaka, Shinichiro Hashimoto, Yasumasa Sugita, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|June 19, 2012
Hepatitis B reactivation in a multiple myeloma patient with resolved hepatitis B infection during bortezomib therapy : case reportHiroaki Tanaka, Ikuo Sakuma, Shinichiro Hashimoto, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|December 27, 2013
Secondary neurolymphomatosis detected by whole-body diffusion-weighted magnetic resonance imaging: a case reportHiroaki Tanaka, Kazuhiro Yoshino, Emiko Sakaida, et al.
Journal of Arrhythmia|October 13, 2017
Adaptive cardiac resynchronization therapy for dilated cardiomyopathy with functional mitral regurgitationYoshiki Nagata, Yoichiro Nakagawa, Yusuke Takeda, et al.
International Journal of Molecular Sciences|May 20, 2017
SGLT2 Inhibitors as a Therapeutic Option for Diabetic NephropathyDaiji Kawanami, Keiichiro Matoba, Yusuke Takeda, et al.
JMA Journal|November 5, 2020
ROCK Inhibition May Stop Diabetic Kidney DiseaseKeiichiro Matoba, Yusuke Takeda, Yosuke Nagai, et al.
Clinics and Practice|July 25, 2024
A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline TreatmentHiroshi Ureshino, Yusuke Takeda, Kazuharu Kamachi, et al.
Neuroimage|July 1, 2023
Sensor array design of optically pumped magnetometers for accurately estimating source currentsYusuke Takeda, Tomohiro Gomi, Ryu Umebayashi, et al.
International Journal of Molecular Sciences|August 19, 2017
Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic NephropathyKeiichiro Matoba, Daiji Kawanami, Yosuke Nagai, et al.
Pageof 13